fda glp 1 green list Food and Drug Administration Launches “Green List” for GLP-1 Drug FDA Demurs on GLP-1 Compounding

While semaglutide curbs appetite and promotes consistent weight reduction, sermorelin supports your bodys ability to repair, rebuild, and stay strong

When you restore physiological levels correctly, you get real, visible improvements in skin quality, wound healing, and hair follicle health

That projection starts with first half 2025 semaglutide sales of about $16.4 billion (Ozempic about $9.4 billion, Wegovy roughly $5.4 billion, Rybelsus about $1.7 billion), annualizes that run rate to approximately $33 billion for full-year 2025, and incorporates Novos statement that recent U.S

Additionally, patients will receive guidance on hydration and lifestyle adjustments that can support recovery, such as dietary recommendations and the importance of rest